Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Initiating oral fingolimod treatment in patients with multiple sclerosis.
The effects of clinical interventions on health-related quality of life in multiple sclerosis: a meta-analysis.
Evoked potentials in multiple sclerosis.
A wireless body measurement system to study fatigue in multiple sclerosis.
Theiler's murine encephalomyelitis virus induced phenotype switch of microglia in vitro.
Diffusion tensor imaging in pediatric transverse myelitis: A case study.
Possible induction of acute disseminated encephalomyelitis (ADEM)-like demyelinating illness by intrathecal mesenchymal stem cell injection.
Tumor necrosis factor beta NcoI polymorphism is associated with inflammatory and metabolic markers in multiple sclerosis patients.
Exercise, brain, and cognition across the life span.
The specific antigen approach in multiple sclerosis: Can it ever be enough?
Optic Nerve and its Arterial-Venous Vascularization: An Ultrasonologic Study in Multiple Sclerosis Patients and Healthy Controls.
Neurochemistry of Hypomyelination Investigated with MR Spectroscopy.
Leg spasticity and ambulation in multiple sclerosis.
A novel method for calculating prevalence of multiple sclerosis in Australia.
[Assessment of the risk of the transition of a monofocal clinically isolated syndrome to clinically definite multiple sclerosis.]
Low body weight linked to PML risk with natalizumab in MS
Involvement of JAK/STAT signaling in the effect of cornel iridoid glycoside on experimental autoimmune encephalomyelitis amelioration in rats.
Fingolimod in the treatment of relapsing-remitting multiple sclerosis: long-term experience and an update on the clinical evidence.
Evidence-based guidelines: MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis-establishing disease prognosis and monitoring patients.
Validity of the Dynamic Gait Index in People With Multiple Sclerosis.
Confounding underlies the apparent 'month of birth' effect in multiple sclerosis.
Cognitive impairment among different clinical courses of multiple sclerosis.
Neuroimmunology: Cyclosporine A and azathioprine are effective adjunctive treatments for neuromyelitis optica.
Low-level laser therapy ameliorates disease progression in a mouse model of multiple sclerosis.
Central nervous system B-cell lymphoma in multiple sclerosis.

Pages